ARWR Arrowhead Pharmaceuticals, Inc.

1.57
-0.03  -2%
Previous Close 1.60
Open 1.60
Price To book 1.27
Market Cap 117.39M
Shares 74,772,000
Volume 350,039
Short Ratio 13.41
Av. Daily Volume 721,625

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Announced that development will be discontinued - November 29, 2016.
ARC-AAT
Alpha-1 antitrypsin deficiency (AATD)
Announced that development will be discontinued - November 29, 2016.
ARC-521
Chronic Hepititis B (HBV)
Announced that development will be discontinued - November 29, 2016.
ARC-520 injection in combination with entecavir or tenofovir
Chronic Hepititis B (HBV)

Latest News

  1. ETFs with exposure to Arrowhead Pharmaceuticals, Inc. : May 26, 2017
  2. Edited Transcript of ARWR earnings conference call or presentation 3-May-17 8:30pm GMT
  3. Arrowhead Pharmaceuticals, Inc. :ARWR-US: Earnings Analysis: Q2, 2017 By the Numbers : May 5, 2017
  4. Today's Research Reports on Arrowhead Pharmaceuticals and Paratek Pharmaceuticals Post Earnings
  5. Arrowhead Reports Fiscal 2017 Second Quarter Results
  6. Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results
  7. Arrowhead Pharmaceuticals Presents ARC-AAT Clinical Data at The International Liver Congress™
  8. Arrowhead Presents ARC-520 and ARC-521 Clinical Data at The International Liver Congress™
  9. ETFs with exposure to Arrowhead Pharmaceuticals, Inc. : April 19, 2017
  10. Arrowhead Pharmaceuticals Announces Presentations at The International Liver Congress™
  11. ETFs with exposure to Arrowhead Pharmaceuticals, Inc. : March 27, 2017
  12. Arrowhead Pharmaceuticals Adopts Stockholder Rights Agreement
  13. Arrowhead Pharmaceuticals, Inc. :ARWR-US: Earnings Analysis: Q1, 2017 By the Numbers : March 21, 2017
  14. SBPH: 2016 Results Sustaining Continued HBV/STING Development
  15. These 5 Stocks Under $10 Could Explode Higher
  16. Edited Transcript of ARWR earnings conference call or presentation 6-Feb-17 9:30pm GMT
  17. Arrowhead Research reports 1Q loss
  18. Arrowhead Reports Fiscal 2017 First Quarter Results
  19. Drug Approvals Expected to Rise as Trump Pledges to Speed Up Approval Process: Latest Reports on Arrowhead Pharmaceuticals and Jaguar Animal Health
  20. Arrowhead Pharmaceuticals to Webcast Fiscal 2017 First Quarter Results